Objective: Bleeding is a rare and dangerous complication of thyroid surgery. One of the hemostatic agents used during surgery are microporous polysaccharide hemospheres (MPH) which are local hemostatic agents acquired from purified potato starch. The aim of this study was to evaluate the efficiency of two MPH, produced with different biotechniques, in decreasing hemorrhages and drainage following thyroidectomy.
IntRODuCtIOn
Thyroidectomy operation is one of the most common endocrine surgical procedures worldwide (1) . Thyroidectomy is frequently performed for nodular goiter and thyroid cancer. Major complications include laryngeal nerve injury, hypoparathyroidism and wound complications (hematoma, seroma, infection etc.) (2) (3) (4) (5) .
Hemostasis is critical during surgery. Inadequate hemostasis can cause postoperative hematoma, wound dehiscence, infection and prolonged hospital stay (6) . Most of the time, adequate hemostasis is ensured with proper surgical method, electrocauterization, suturation and bipolar sealing devices (5, 7, 8) . Additionally, adrenaline packs and local hemostatic agents can be used for oozing hemorrhages (9) . Bleeding is a rare complication of thyroid surgery. However, when it occurs, it carries severe morbidity and mortality risks (10) (11) (12) . Even a hemorrhage of 20-30 ml may result in death by causing tracheal compression and airway obstruction (13) . To prevent this complication, generally drainage tubes are placed during the surgical procedure.
One of the hemostatic agents used during surgery is microporous polysaccharide hemospheres (MPH) which are local hemostatic agents derived as a product of advanced BioEngineering from purified potato starch. MPH incorporate a sophisticated, plant-based polymer crosslinking that creates ultra-hydrophilic, biocompatible particles. They facilitate the coagulation cascade by absorbing the liquid portion of the blood and increasing the concentration of the platelets and coagulation factors (14) (15) (16) . Clotting process begins on contact, regardless of patient's coagulation status. MPH provides broad area coverage on rough surfaces and in hard-to-reach areas. MPH are indicated in surgical procedures except neurologic and ophthalmic as an adjunctive hemostatic device to assist when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures are ineffective or impractical.
This study aimed to evaluate the efficiency of two MPH, produced with different biotechniques including Haemocer TM and Arista TM, in decreasing hemorrhages and drainage following thyroidectomy. Thereby, an effective hemostatic agent would ensure better cosmetic results and extinguish drainage replacement.
MAtERIAl and MEthODs
Totally, 60 patients (20 patients per each group) were predicted in statistical power analysis within 95% confidence interval. Subsequent to local human ethics committee approval, a group of 60 patients (12 males, 48 females, average age: 45, age range: 12-67 years) were enrolled prospectively. Study group consisted of euthyroid patients admitted to the Endocrine surgery outpatient clinic between January and December 2013, and scheduled to undergo total thyroidectomy. Thyroidectomy indications were malignancy, suspicious malignancy, nodules larger than 4 cm, Basedow-Graves disease and symptomatic multi-nodular goitre like dyspnea and etc. Informed consent was obtained from all participants for both the operation they would undergo and the study they would be enrolled in. Exclusion criteria were administration of anticoagulant agents, central or/and lateral lymph node dissection for malignancy or for any reason, and patient refusal of operation or study participation. Patients were divided into three groups; first being the control group, second being Haemocer TM (Bio Cer Entwicklungs-GmbH, Bayreuth, Germany) group and third being Arista TM (Bard Davol Inc., Werwick, United Kingdom) group respectively. The three treatments are randomized on Microsoft Excel 2016 ® program for 20 patients in each group.
The researcher informed the surgeon in the operation room for each patient. First operation belonging to the control group, all 60 patients underwent the procedure consequently. The same surgeon performed bilateral total thyroidectomy on all patients. Following bilateral total thyroidectomy, no additional procedures were performed in the first group, 5 g Haemocer TM was administered to the second group, 5 g Arista TM was administered to the third group into the operational field. And the operation was ended by placing a double-sided hemovac drain. The thyroidectomy material was weighted perioperatively. Although there is not any effect for hypocalcemia of MPH, they may cause hypoperfusion of the parathyroid glands while covering the surgical site for hemostasis. On post-operative day one, drainage amount, calcium (Ca), phosphate (P) and parathyroid hormone (PTH) levels were noted.
statistical Analysis
Totally, 60 patients (20 patients per each group) were predicted in statistical power analysis within 95% confidence interval. The statistical analyses were performed using SPSS v20. KruskalWallis Chi-Square test was used for intergroup comparison. Data was evaluated within 95% Confidence Interval and with p< 0.05 significance level.
REsults
Information regarding age, gender, removed tissue weight and malignant pathology rates of the groups are shown on Table  1 . No significant difference was noted between the groups for age, gender, removed tissue weight and malignant pathology rates.
No significant difference was noted between post-operative drainages and Ca, P, PTH levels of the groups, either. Hoarseness, surgical site infection or hematoma was not observed in any patient. Post-operative day one drainage amounts and Ca, P, PTH levels are shown on Table 2 .
On post-operative day one, asymptomatic hypocalcemia was noted for four patients in group one, two patients in group two and four patients in group three. Outpatient clinic controls revealed normal calcium levels for all patients on post-operative day 15 after conservative follow-up. 
DIsCussIOn
Since the day it was identified, haemorrhage has been one of the most feared complications of thyroidectomy. Despite the advances in surgical method and instruments with its rare occurrence; post-operative hematoma remains to cause severe mortality and morbidity risks (9,11).
Post-operative hematoma may cause airway obstruction due to larynx compression and impairment in venous and lymphatic drainage (11, 12) .
Slipping of ligatures, re-opening of coagulated veins or leakage from remnant thyroid tissue have been suggested for the etiology of bleeding following thyroidectomy (11, 12) . Hurtado et al. have stated that postoperative bleeding is present in patients with remnant thyroid tissue, especially the ones with hyperfunctioning thyroid diseases; yet they have failed to prove it statistically (17) . Bergamashi et al. have not been able to show the association between the extension of thyroidectomy and post-operative hematoma either (18) . However; in a large multicentered study, hematoma consisted 8% of all complications, and with a rate of 2%, it has been found to be most frequent in patients with bilateral subtotal thyroidectomy operation (19) . Primary efficiency of local hemostatic agents are seen in oozing hemorrhages (7) .
MPH are relatively new additions to the hemostatic agents family. They are acquired from purified potato starch. Absorbing the liquid portion of the blood, they increase the concentration of platelets and coagulation factors and facilitate the coagulation cascade. By this way, a thick, viscose clot formation occurs and then fibrin coat takes place (14-16).
Local hemostatic agents are involved in different fields clinically. They are especially used in liver resections, spleen injuries, kidney operations and orthopedic surgery frequently (14) (15) (16) 20 (23) . Also, Sielaff et al., in their multi-centre study, have assessed the efficiency of gelatine-based sponge as a local hemostatic agent in thyroid surgery. According to the results of 87 thyroidectomy cases, it has been found to be safe and efficient as a local hemostatic agent in thyroid surgery (24) .
To the best of our knowledge, this is the first study to evaluate the efficiency of Haemocer TM and Arista TM in thyroid surgery. been achieved. Neither product has been found to be superior in terms of bleeding reducing activity. MPH administration had no effect on post-operative Ca, P and PTH levels. It did not affect the hoarseness and infection rates either.
COnClusIOn
MPH are relatively expensive products that got in use empirically in thyroid surgery. However, there is no scientific evidence regarding their role in thyroid surgery. Based on data from our study, MPH are yet to be proven effective in decreasing postoperative hemorrhages and this might be a key to avoiding unnecessary expenses.
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